You are here: Home » PTI Stories » National » News
Business Standard

Suven Life gets product patents from New Zealand, USA

Press Trust of India  |  New Delhi 

Sciences today said it has been granted a product by and USA each corresponding to a (NCE) for treatment of associated with

These patents are valid through 2034, the company said in a BSE filing.

"We are pleased by the grant of these patents to Suven for our pipeline of molecules in the CNS arena, which are being developed for with high unmet medical need with a huge market potential globally," said.

The granted claims of patents are being developed as therapeutic agents useful in associated with like Alzheimer's disease, (ADHD), Huntington's disease, and and and sleep disorders such as Narcolepsy, it added.

Sciences shares were trading 2.13 per cent down at Rs 192.60 on BSE.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Tue, May 29 2018. 13:05 IST